1.Ten-year trends in antibiotic usage at a tertiary care hospital in Korea, 2004 to 2013
Bongyoung KIM ; Hyeonjun HWANG ; Jieun KIM ; Myoung-jae LEE ; Hyunjoo PAI
The Korean Journal of Internal Medicine 2020;35(3):703-713
Background/Aims:
This study was performed to evaluate trends in antibiotic usage at a tertiary care hospital in Korea.
Methods:
This study collated antibiotic prescription data and total patient days for inpatients at a tertiary care hospital in Korea between 2004 and 2013. The consumption of each class of antibiotic was converted to defined daily dose (DDD)/1,000 patient-days. We defined 3rd generation cephalosporins, 4th generation cephalosporins, β-lactam/β-lactamase inhibitors, and fluoroquinolones as broad-spectrum antibiotics; carbapenems, tigecycline, glycopeptides, oxazolidinone, and polymyxin were defined as antibiotics against multidrug-resistant (MDR) pathogens. Other antibiotic classes were defined as nonbroad-spectrum antibiotics.
Results:
Mean antibiotic consumption was 920.69 DDD/1,000 patient-days. The proportions of broad-spectrum antibiotics, antibiotics against MDR pathogens, and nonbroad-spectrum antibiotics were 41.8% (384.48/920.69), 3.5% (32.24/920.69), and 54.7% (503.97/920.69), respectively. Consumption of broad-spectrum antibiotics (coefficient for time 0.141; p = 0.049) and antibiotics against MDR pathogens (coefficient for time 0.185; p < 0.001) showed a significant increasing trend over the study period. Nonbroad-spectrum antibiotic consumption showed a significant decreasing trend over the study period (coefficient for time –2.601; p < 0.001).
Conclusions
Over the 10-year period, a stepwise increase in the consumption of broad-spectrum antibiotics and antibiotics against MDR pathogens was observed at a tertiary care hospital in Korea. Conversely, during the same period, nonbroad-spectrum antibiotic consumption showed a significant decreasing trend.
2.Insertion of Totally Implantable Central Venous Access Devices by Surgeons.
Hyeonjun AN ; Chun Geun RYU ; Eun Joo JUNG ; Hyun Jong KANG ; Jin Hee PAIK ; Jung Hyun YANG ; Dae Yong HWANG
Annals of Coloproctology 2015;31(2):63-67
PURPOSE: The aim of this study is to evaluate the results for the insertion of totally implantable central venous access devices (TICVADs) by surgeons. METHODS: Total 397 patients, in whom TICVADs had been inserted for intravenous chemotherapy between September 2008 and June 2014, were pooled. This procedure was performed under local anesthesia in an operation room. The insertion site for the TICVAD was mainly in the right-side subclavian vein. In the case of breast cancer patients, the subclavian vein opposite the surgical site was used for insertion. RESULTS: The 397 patients included 73 males and 324 females. Primary malignant tumors were mainly colorectal and breast cancer. The mean operation time was 54 minutes (18-276 minutes). Operation-related complications occurred in 33 cases (8.3%). Early complications developed in 15 cases with catheter malposition and puncture failure. Late complications, which developed after 24 hours, included inflammation in 6 cases, skin necrosis in 6 cases, hematoma in 3 cases, port malfunction in 1 case, port migration in 1 case, and intractable pain at the port site in 1 case. CONCLUSION: Insertion of a TICVAD under local anesthesia by a surgeon is a relatively safe procedure. Meticulous undermining of the skin and carefully managing the TICVAD could minimize complications.
Anesthesia, Local
;
Breast Neoplasms
;
Catheterization, Central Venous
;
Catheters
;
Drug Therapy
;
Female
;
Hematoma
;
Humans
;
Inflammation
;
Maintenance Chemotherapy
;
Male
;
Necrosis
;
Pain, Intractable
;
Punctures
;
Skin
;
Subclavian Vein
;
Vascular Access Devices
3.Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice.
Eun Jin MOON ; Il Gyu KO ; Sung Eun KIM ; Jun Jang JIN ; Lakkyong HWANG ; Chang Ju KIM ; Hyeonjun AN ; Bong Jae LEE ; Jae Woo YI
International Neurourology Journal 2018;22(Suppl 3):S139-S146
PURPOSE: Sleep deprivation induces depressive symptoms. Dexmedetomidine is a α2-adrenoreceptor agonist and this drug possesses sedative, anxiolytic, analgesic, and anesthetic-sparing effect. In this study, the action of dexmedetomidine on sleep deprivation-induced depressive behaviors was investigated using mice. METHODS: For the inducing of sleep deprivation, the mice were placed inside a water cage containing 15 platforms and filled with water up to 1 cm below the platform surface for 7 days. One day after sleep deprivation, dexmedetomidine at the respective dosage (0.5, 1, and 2 μg/kg) was intraperitoneally treated into the mice, one time per a day during 6 days. Then, forced swimming test and tail suspension test were conducted. Immunohistochemistry for tyrosine hydroxylase (TH), 5-hydroxytryptamine (5-HT; serotonin), tryptophan hydroxylase (TPH) and western blot for D1 dopamine receptor were also performed. RESULTS: Sleep deprivation increased the immobility latency in the forced swimming test and tail suspension test. The expressions of TPH, 5-HT, and D1 dopamine receptor were decreased, whereas, TH expression was increased by sleep deprivation. Dexmedetomidine decreased the immobility latency and increased the expressions of TPH, 5-HT, and D1 dopamine receptor, whereas, HT expression was decreased by dexmedetomidine treatment. CONCLUSIONS: In our results, dexmedetomidine alleviated sleep deprivation-induced depressive behaviors by increasing 5-HT synthesis and by decreasing dopamine production with up-regulation of D1 dopamine receptor.
Animals
;
Blotting, Western
;
Depression
;
Dexmedetomidine*
;
Dopamine
;
Hindlimb Suspension
;
Immunohistochemistry
;
Mice*
;
Physical Exertion
;
Receptors, Dopamine
;
Serotonin
;
Sleep Deprivation
;
Tryptophan Hydroxylase
;
Tyrosine 3-Monooxygenase
;
Up-Regulation
;
Water